This site uses cookies. By continuing to use this site you agree to our use of cookies. To find out more, see our Privacy and Cookies policy. Close this notification
Brought to you by:
Paper The following article is Open access

Molecular Docking of Quinine Derivative as Inhibitor in Sars-Cov-2

, , and

Published under licence by IOP Publishing Ltd
, , Citation Destria Roza et al 2021 J. Phys.: Conf. Ser. 1819 012053 DOI 10.1088/1742-6596/1819/1/012053

1742-6596/1819/1/012053

Abstract

The discovery of various of new medicinal compounds from various research clarifies the important role of computational studies as the initial basis for finding sources of medicinal raw materials both from natural and synthetic. SARS-coronavirus 2 (SARS-CoV-2) or COVID-19 is the virus which is responsible for the outbreak that affects almost the entire world began in early 2020. This study aim is to determine the interaction between SARS-CoV-2 and quinine derivative compounds by utilizing and developing quinine plants as medicinal ingredients, especially Corona antivirus. The research was conducted in silico with the molecular docking method. The docking software used in this research is AutodockVina. The results showed that from the 10 tested compounds against SARS-CoV-2 virus cells, all of ithas the ability as an antivirus with the binding affinity of around -6 kcal / mol. The native ligands have the best binding affinity among the tested compounds which is around -7.9 kcal / mol. This is also supported by the number of hydrogen bondings and bond lengths as well.

Export citation and abstract BibTeX RIS

Content from this work may be used under the terms of the Creative Commons Attribution 3.0 licence. Any further distribution of this work must maintain attribution to the author(s) and the title of the work, journal citation and DOI.

Please wait… references are loading.
10.1088/1742-6596/1819/1/012053